FDA conducts inspection at Odacrem Coffee, LLC in Albuquerque on Jan. 26, 2024

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA - Official Website
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA - Official Website
0Comments

The Food and Drug Administration inspected Odacrem Coffee, LLC in Albuquerque on January 26, 2024, to assess potential foodborne biological hazards, according to data posted on the FDA’s website.

The FDA’s final report concluded that Odacrem Coffee, LLC was not required to take any corrective actions regarding its operational management.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA - Official Website

El Encanto, Incorporated in Albuquerque inspected by FDA on April 18, 2024

On April 18, 2024, the Food and Drug Administration conducted an inspection of El Encanto, Incorporated in Albuquerque focusing on foodborne biological hazards and the oversight of marketed animal drugs, feed, and devices, according to information available on the FDA’s website.

Jim Jones Deputy Commissioner for Human Foods of FDA - Official Website

UNM Hospitals in Albuquerque inspected by FDA on July 26, 2024

On July 26, 2024, the FDA conducted an inspection at UNM Hospitals in Albuquerque, focusing on blood and blood products as well as human cellular, tissue, and gene therapies, according to information available on the FDA’s website.

Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) - Official website

FDA conducts inspection of Cardinal Health 414, LLC in Albuquerque on Sept. 25, 2024

Cardinal Health 414, LLC in Albuquerque underwent an FDA inspection on September 25, 2024, focusing on drug quality assurance, according to information posted on the FDA’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from ABQ Times.